Closing the gap between innovation and adoption.

Closing the gap between innovation and adoption.

We help ambitious health and life sciences companies turn breakthrough innovation into real-world adoption, scale and growth.

We help ambitious health and life sciences companies turn breakthrough innovation into real-world adoption, scale and growth.

Evidence. Policy. Brand. Go-to-market. Senior judgement for the moments that matter.

Evidence. Policy. Brand. Go-to-market. Senior judgement for the moments that matter.

WHAT WE DO

From innovation to impact

From innovation to impact

We work at the intersection of innovation, policy, brand and adoption.

We work at the intersection of innovation, policy, brand and adoption.

Navigate the NHS and health ecosystem

We help companies understand how health systems really work: the decision-makers, policy environment, clinical pathways and partnerships that determine whether innovation gets adopted.

Shape policy and influence

We anticipate political, policy and regulatory change, build influential relationships and help create the conditions in which innovation can succeed.

Brand, positioning and narrative

We turn complex science and technology into clear, compelling propositions — developing brand and positioning strategies that build trust, reputation and demand.

Go-to-market and growth

We develop UK and US market-entry and GTM strategies, helping leadership teams connect brand, communications, stakeholder engagement and commercial objectives.

Strategic campaigns

From major launches and funding rounds to policy change, reputation and corporate inflection points, we design and deliver campaigns that move organisations forward.

WHY JARVIS ASSOCIATES

The gap between invention and adoption is where many brilliant companies get stuck.

The gap between invention and adoption is where many brilliant companies get stuck.

The science may be strong. The technology may work. The investment may be there.

But adoption requires something different: understanding the system around the innovation.

Who needs to believe in it?

Who needs to believe in it?

Who makes the decision?

Who makes the decision?

What evidence will persuade them?

What evidence will persuade them?

What policy needs to change?

What policy needs to change?

How should the company be positioned?

How should the company be positioned?

What story will make people care?

What story will make people care?

How does all of that translate into commercial growth?

How does all of that translate into commercial growth?

That’s the gap Jarvis Associates exists to close. We combine senior strategic counsel with hands-on execution, working with founders, leadership teams and investors at critical moments of growth.

WHO WE ARE

System influence. Market influence.

System influence. Market influence.

SJ

Sian Jarvis CB

Founder

Sian is a board-level communications, policy and corporate affairs leader with extensive experience across government, the NHS, healthcare and life sciences. A former Director General at the Department of Health and NHS, she has advised Secretaries of State, led major national health campaigns and subsequently held senior roles across healthcare, technology and life sciences. Most recently she was Chief Policy and Corporate Affairs Officer at Genomics, working at the intersection of cutting-edge science, NHS adoption, government policy and commercial growth. She brings senior strategic judgement, deep understanding of the health system and extensive relationships across government, the NHS, healthcare, media and life sciences.

SH

Stephen Hankinson

Brand & Marketing

Stephen is an experienced brand and marketing leader specialising in healthcare, life sciences and growth-stage companies. He helps organisations translate ambitious commercial strategy into distinctive brands, compelling positioning and practical go-to-market plans. His expertise spans brand strategy, creative direction, integrated marketing, digital growth, campaign development and GTM — connecting what a company stands for with the audiences it needs to reach and the commercial outcomes it needs to achieve.

Together, we combine system influence with market influence: helping clients create the environment for adoption while building the brand and demand required for growth.

Together, we combine system influence with market influence: helping clients create the environment for adoption while building the brand and demand required for growth.

HOW WE WORK

Small team. Senior counsel. Material difference.

Small team. Senior counsel. Material difference.

We work with a small number of clients where we believe we can make a material difference. Our engagements typically take three forms:

We work with a small number of clients where we believe we can make a material difference. Our engagements typically take three forms:

Fractional leadership

Senior C-suite counsel without the cost or commitment of building a full senior function.

Go-to-market & launch

Focused support around market entry, NHS adoption, launches and major growth milestones.

Strategic projects & campaigns

Intensive programmes around policy, positioning, brand, funding, reputation or significant corporate moments.

We can work as senior advisers, provide hands-on delivery, or build a specialist team around the challenge.

We can work as senior advisers, provide hands-on delivery, or build a specialist team around the challenge.

WHO WE WORK WITH

The people moving health forward.

The people moving health forward.

Growth-stage companies

Growth-stage companies

Health tech, life sciences, genomics, digital health, AI and other science-led businesses moving from innovation towards adoption and scale.

Health tech, life sciences, genomics, digital health, AI and other science-led businesses moving from innovation towards adoption and scale.

Founders and leadership teams

Founders and leadership teams

Teams who need experienced senior counsel at a critical stage, without building a large permanent corporate affairs and marketing infrastructure.

Teams who need experienced senior counsel at a critical stage, without building a large permanent corporate affairs and marketing infrastructure.

Investors

Investors

VC and private equity firms seeking strategic support for portfolio companies around positioning, market entry, reputation, policy and growth.

VC and private equity firms seeking strategic support for portfolio companies around positioning, market entry, reputation, policy and growth.

TRACK RECORD

TRACK RECORD

Proof, not promises.

Proof, not promises.

  • $130m

    Series C raised

    $12m+

    contracts generated through lead-generation activity

    Multi-million

    global pharma contracts

    167%

    increase in brand impressions

    150%

    audience growth

    37%

    increase in patient sign-ups

    NHS + Government

    engagement leading to direct policy and commercial outcomes

    FT · BBC · Bloomberg

    national and international coverage

  • $130m

    Series C raised

    $12m+

    contracts generated through lead-generation activity

    Multi-million

    global pharma contracts

    167%

    increase in brand impressions

    150%

    audience growth

    37%

    increase in patient sign-ups

    NHS + Government

    engagement leading to direct policy and commercial outcomes

    FT · BBC · Bloomberg

    national and international coverage

START A CONVERSATION

Have an innovation that should be changing healthcare?

Have an innovation that should be changing healthcare?

If the science works but adoption, positioning or growth isn’t moving fast enough, let’s talk.

If the science works but adoption, positioning or growth isn’t moving fast enough, let’s talk.

Strategic advisory for ambitious health and life sciences companies.

Strategic advisory for ambitious health and life sciences companies.